12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder. Stein, D J, Khoo, J P, Ahokas, A, Jarema, M, Van Ameringen, M, Vavrusova, L, Hӧschl, C, Bauer, M, Bitter, I, Mosolov, S N, Olivier, V, Matharan, S, Picarel-Blanchot, F, & de Bodinat, C European Neuropsychopharmacology, 28(8):970–979, 2018. ![12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi bibtex @article{Stein2018b,
title = {12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder},
volume = {28},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049594777&doi=10.1016%2Fj.euroneuro.2018.05.006&partnerID=40&md5=5f86802377e06b860107263afc757430},
doi = {10.1016/j.euroneuro.2018.05.006},
number = {8},
journal = {European Neuropsychopharmacology},
author = {Stein, D J and Khoo, J P and Ahokas, A and Jarema, M and Van Ameringen, M and Vavrusova, L and Hӧschl, C and Bauer, M and Bitter, I and Mosolov, S N and Olivier, V and Matharan, S and Picarel-Blanchot, F and de Bodinat, C},
year = {2018},
pages = {970--979},
}
Downloads: 0
{"_id":"au3agkwKoMBvNcYaY","bibbaseid":"stein-khoo-ahokas-jarema-vanameringen-vavrusova-hschl-bauer-etal-12weekdoubleblindrandomizedmulticenterstudyofefficacyandsafetyofagomelatine2550mgdayversusescitalopram1020mgdayinoutpatientswithseveregeneralizedanxietydisorder-2018","downloads":0,"creationDate":"2019-02-13T11:06:59.795Z","title":"12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder","author_short":["Stein, D J","Khoo, J P","Ahokas, A","Jarema, M","Van Ameringen, M","Vavrusova, L","Hӧschl, C","Bauer, M","Bitter, I","Mosolov, S N","Olivier, V","Matharan, S","Picarel-Blanchot, F","de Bodinat, C"],"year":2018,"bibtype":"article","biburl":"https://bibbase.org/zotero/uct_neuroscience?iframe=true","bibdata":{"bibtype":"article","type":"article","title":"12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder","volume":"28","url":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049594777&doi=10.1016%2Fj.euroneuro.2018.05.006&partnerID=40&md5=5f86802377e06b860107263afc757430","doi":"10.1016/j.euroneuro.2018.05.006","number":"8","journal":"European Neuropsychopharmacology","author":[{"propositions":[],"lastnames":["Stein"],"firstnames":["D","J"],"suffixes":[]},{"propositions":[],"lastnames":["Khoo"],"firstnames":["J","P"],"suffixes":[]},{"propositions":[],"lastnames":["Ahokas"],"firstnames":["A"],"suffixes":[]},{"propositions":[],"lastnames":["Jarema"],"firstnames":["M"],"suffixes":[]},{"propositions":[],"lastnames":["Van","Ameringen"],"firstnames":["M"],"suffixes":[]},{"propositions":[],"lastnames":["Vavrusova"],"firstnames":["L"],"suffixes":[]},{"propositions":[],"lastnames":["Hӧschl"],"firstnames":["C"],"suffixes":[]},{"propositions":[],"lastnames":["Bauer"],"firstnames":["M"],"suffixes":[]},{"propositions":[],"lastnames":["Bitter"],"firstnames":["I"],"suffixes":[]},{"propositions":[],"lastnames":["Mosolov"],"firstnames":["S","N"],"suffixes":[]},{"propositions":[],"lastnames":["Olivier"],"firstnames":["V"],"suffixes":[]},{"propositions":[],"lastnames":["Matharan"],"firstnames":["S"],"suffixes":[]},{"propositions":[],"lastnames":["Picarel-Blanchot"],"firstnames":["F"],"suffixes":[]},{"propositions":["de"],"lastnames":["Bodinat"],"firstnames":["C"],"suffixes":[]}],"year":"2018","pages":"970–979","bibtex":"@article{Stein2018b,\n\ttitle = {12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder},\n\tvolume = {28},\n\turl = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049594777&doi=10.1016%2Fj.euroneuro.2018.05.006&partnerID=40&md5=5f86802377e06b860107263afc757430},\n\tdoi = {10.1016/j.euroneuro.2018.05.006},\n\tnumber = {8},\n\tjournal = {European Neuropsychopharmacology},\n\tauthor = {Stein, D J and Khoo, J P and Ahokas, A and Jarema, M and Van Ameringen, M and Vavrusova, L and Hӧschl, C and Bauer, M and Bitter, I and Mosolov, S N and Olivier, V and Matharan, S and Picarel-Blanchot, F and de Bodinat, C},\n\tyear = {2018},\n\tpages = {970--979},\n}\n\n\n\n","author_short":["Stein, D J","Khoo, J P","Ahokas, A","Jarema, M","Van Ameringen, M","Vavrusova, L","Hӧschl, C","Bauer, M","Bitter, I","Mosolov, S N","Olivier, V","Matharan, S","Picarel-Blanchot, F","de Bodinat, C"],"key":"Stein2018b","id":"Stein2018b","bibbaseid":"stein-khoo-ahokas-jarema-vanameringen-vavrusova-hschl-bauer-etal-12weekdoubleblindrandomizedmulticenterstudyofefficacyandsafetyofagomelatine2550mgdayversusescitalopram1020mgdayinoutpatientswithseveregeneralizedanxietydisorder-2018","role":"author","urls":{"Paper":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049594777&doi=10.1016%2Fj.euroneuro.2018.05.006&partnerID=40&md5=5f86802377e06b860107263afc757430"},"metadata":{"authorlinks":{}},"downloads":0},"search_terms":["week","double","blind","randomized","multicenter","study","efficacy","safety","agomelatine","day","versus","escitalopram","day","out","patients","severe","generalized","anxiety","disorder","stein","khoo","ahokas","jarema","van ameringen","vavrusova","hӧschl","bauer","bitter","mosolov","olivier","matharan","picarel-blanchot","de bodinat"],"keywords":[],"authorIDs":[],"dataSources":["mwTox26pHWwQd9xuw","6STvEtq6QvB8pQwSw"]}